This episode unpacks the updated BCLC guidelines for hepatocellular carcinoma management. Experts discuss the strengths and limitations of the BCLC model in an era of rapidly evolving systemic therapies and personalised care, sharing real-world examples of when the algorithm helps and when clinical practice diverges.

Host: Mattias Mandorfer
Speakers: Marco Sanduzzi, Lorenza Rimassa

This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-05

As deaths from advanced chronic liver disease rise, many patients never receive timely palliative care.

In this episode, we explore why early, holistic support is essential in advanced liver disease and HCC, and unpack key recommendations from the new EASL Position Paper to help reduce suffering and improve quality of life.

Host: Debbie Shawcross
Speakers: Patrizia-Künzler-Heule, Sumita Verma

This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-04

This episode explores whether MetALD is a meaningful clinical entity or an unnecessary complication. Experts discuss the overlap between metabolic dysfunction and alcohol use, the challenges of applying the MetALD definition in practice, and its impact on classification, guidelines, drug development, and patient care.

Host: Thomas Marjot
Speakers: Mary Rinella , Aleksander Krag

This episode is also available on EASL Campus: https://easlcampus.eu/tltm/episode-03